A Ga-FAPI-04 PET/CMR study found that 74% of post-ablation atrial fibrillation patients showed increased atrial fibroblast ...

A 25-year-old man's recurrent palpitations were finally traced to a rare upper septal fascicular ventricular tachycardia that ...

Cardiac arrhythmias are a leading cause of morbidity and mortality worldwide. Catheter ablation provides a minimally invasive means to target and eliminate arrhythmogenic substrates within the heart.

Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation System for ventricular tachycardia (VT), have been published in Circulation.

Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...

The first randomized trial to investigate preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic total occlusion (CTO) in patients at high risk of ventricular ...

CHICAGO -- For patients with ventricular tachycardia (VT) and ischemic cardiomyopathy, going right to catheter ablation improved outcomes compared with trying antiarrhythmic drugs first, the VANISH2 ...

A new, multicenter study demonstrated that ablation treatment may be a better first option than medication for many heart attack survivors who develop abnormal electrical short circuits in their heart ...

For ventricular tachycardia (VT), catheter ablation is often seen as an option of last resort, however, some are questioning whether there has been too much emphasis on antiarrhythmic medication. In ...